Skip to main content
Premium Trial:

Request an Annual Quote

Putting the Brakes on Direct-to-Consumer Genome Scans

Harvard's David Hunter tells U.S. News and World Report that the scans popping up in the marketplace aren't yet useful for making health decisions for individuals. He has three main concerns about consumers using this technology, namely that they might lull people into a "false sense of security" if their risky genes haven't yet been identified, the overwhelming nature of finding out about multiple disease risks at once, and, lastly, the immature state of knowledge -- the information will need to be updated constantly. "Then there's this other extra area of how to responsibly communicate the information. That needs to be thought through very carefully so we don't do more harm than good," adds Hunter.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.